In this randomized, controlled trial involving asymptomatic adults 50 to 69 years of age, we compared one-time colonoscopy in 26,703 subjects with FIT every 2 years in 26,599 subjects. The primary ...

The number of colonoscopies needed to detect one person with advanced neoplasia was 5.1 for guaiac-positive patients but only 2.7 for immunochemical-test–positive patients. Colonoscopy revealed ...

Fecal immunochemical testing should be performed every 1–2 years, ideally as part of a colorectal cancer screening program1, 2 Fecal immunochemical testing, a stool immunochemical test for occult ...

Background: Previous studies have suggested that the immunochemical fecal occult blood test has superior specificity for detecting bleeding in the lower gastrointestinal tract even if bleeding occurs ...

About The Study: In this nested case-control study, completing fecal immunochemical test was associated with a lower risk of overall death from colorectal cancer, particularly in the left colon, and ...

About The Study: This study found that comparable levels of sensitivity and specificity as reported for the multitarget stool RNA (mt-sRNA) test in the colorectal cancer (CRC)-PREVENT study could be ...

FIT (Faecal Immunochemical Test) is a test that looks for blood in a sample of your poo. It looks for tiny traces of blood that you might not be able to see, and which could be a sign of cancer.

Colorectal cancer (CRC) remains the second leading cause of cancer-related deaths in the United States, a troubling fact when considering that CRC is largely preventable and treatable if caught early.

Fecal Immunochemical Testing (FIT) is usually preferred by people for screening of colorectal cancer. But a higher number of lesions can be detected more clearly using colonoscopy. Though fecal ...

Colonoscopy versus Fecal Immunochemical Testing in Colorectal-Cancer Screening Original Article, N Engl J Med 2012;366:697-706. In the first paragraph of the Statistical Analysis subsection of Methods ...